Unknown PHASE3 INTERVENTIONAL 2-arm NCT04540991

Genotoxicity Assessment of Dental Implants in Gingival Epithelial Cells

Sponsor: Daniel Jerković

Interventions Collecting gingival epithelial cellsusing the swab technique gingiva former placement implant placement

Updated 5 times since 2020 Last updated: Sep 1, 2020 Started: Mar 10, 2020 Primary completion: Mar 20, 2021 Completion: Apr 25, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04540991, this PHASE3 trial focuses on Genotoxicity and remains ongoing. Sponsored by Daniel Jerković, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Oct 2022 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Oct 2022 [monthly]

Active Not Recruiting PHASE3
Oct 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE3

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daniel Jerković

Data source: University of Zagreb

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Split, Croatia